These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

628 related articles for article (PubMed ID: 34774397)

  • 21. Barriers and facilitators to implementing medications for opioid use disorder and naloxone distribution in Veterans Affairs emergency departments.
    Sasson C; Dieujuste N; Klocko R; Basrai Z; Celedon M; Hsiao J; Himstreet J; Hoffman J; Pfaff C; Malmstrom R; Smith J; Holstein A; Johnson-Koenke R
    Acad Emerg Med; 2023 Apr; 30(4):289-298. PubMed ID: 36757683
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Addressing System and Clinician Barriers to Emergency Department-initiated Buprenorphine: An Evaluation of Post-intervention Physician Outcomes.
    Mahal JJ; Bijur P; Sloma A; Starrels J; Lu T
    West J Emerg Med; 2024 May; 25(3):303-311. PubMed ID: 38801034
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Treating opioid use disorder in veterans with co-occurring substance use: a qualitative study with buprenorphine providers in primary care, mental health, and pain settings.
    Frost MC; Soyer EM; Achtmeyer CE; Hawkins EJ; Glass JE; Hallgren KA; Williams EC
    Addict Sci Clin Pract; 2023 May; 18(1):26. PubMed ID: 37143162
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Opioid Use Disorder Treatment Initiation and Continuation: a Qualitative Study of Patients Who Received Addiction Consultation and Hospital-Based Providers.
    Calcaterra SL; Lockhart S; Callister C; Hoover K; Binswanger IA
    J Gen Intern Med; 2022 Aug; 37(11):2786-2794. PubMed ID: 34981359
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Interrupted Time Series of User-centered Clinical Decision Support Implementation for Emergency Department-initiated Buprenorphine for Opioid Use Disorder.
    Holland WC; Nath B; Li F; Maciejewski K; Paek H; Dziura J; Rajeevan H; Lu CC; Katsovich L; D'Onofrio G; Melnick ER
    Acad Emerg Med; 2020 Aug; 27(8):753-763. PubMed ID: 32352206
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Healthcare provider perspectives on emergency department-initiated buprenorphine/naloxone: a qualitative study.
    Badke K; Small SS; Pratt M; Lockington J; Gurney L; Kestler A; Moe J
    BMC Health Serv Res; 2024 Feb; 24(1):211. PubMed ID: 38360620
    [TBL] [Abstract][Full Text] [Related]  

  • 27. "Now hospital leaders are paying attention": A qualitative study of internal and external factors influencing addiction consult services.
    Priest KC; Englander H; McCarty D
    J Subst Abuse Treat; 2020 Mar; 110():59-65. PubMed ID: 31952629
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Emergency Department Clinicians' Attitudes Toward Opioid Use Disorder and Emergency Department-initiated Buprenorphine Treatment: A Mixed-Methods Study.
    Im DD; Chary A; Condella AL; Vongsachang H; Carlson LC; Vogel L; Martin A; Kunzler N; Weiner SG; Samuels-Kalow M
    West J Emerg Med; 2020 Feb; 21(2):261-271. PubMed ID: 32191184
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Contextual barriers and enablers to establishing an addiction-focused consultation team for hospitalized adults with opioid use disorder.
    Evans SK; Ober AJ; Korn AR; Peltz A; Friedmann PD; Page K; Murray-Krezan C; Huerta S; Ryzewicz SJ; Tarhuni L; Nuckols TK; E Watkins K; Danovitch I
    Addict Sci Clin Pract; 2024 Apr; 19(1):31. PubMed ID: 38671482
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Improving transitions of care for patients initiated on buprenorphine for opioid use disorder from the emergency departments in King County, Washington.
    Fockele CE; Duber HC; Finegood B; Morse SC; Whiteside LK
    J Am Coll Emerg Physicians Open; 2021 Apr; 2(2):e12408. PubMed ID: 33778807
    [TBL] [Abstract][Full Text] [Related]  

  • 31. "Just give them a choice": Patients' perspectives on starting medications for opioid use disorder in the ED.
    Schoenfeld EM; Westafer LM; Beck SA; Potee BG; Vysetty S; Simon C; Tozloski JM; Girardin AL; Soares WE
    Acad Emerg Med; 2022 Aug; 29(8):928-943. PubMed ID: 35426962
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Implementing a Novel Statewide Network to Support Emergency Department-initiated Buprenorphine Treatment.
    Clemency BM; Hoopsick RA; Burnett SJ; Kahn LS; Lynch JJ
    West J Emerg Med; 2022 Jun; 23(4):451-460. PubMed ID: 35980408
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Responding to the opioid and overdose crisis with innovative services: The recovery community center office-based opioid treatment (RCC-OBOT) model.
    Ashford RD; Brown AM; McDaniel J; Neasbitt J; Sobora C; Riley R; Weinstein L; Laxton A; Kunzelman J; Kampman K; Curtis B
    Addict Behav; 2019 Nov; 98():106031. PubMed ID: 31326776
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Perspectives About Emergency Department Care Encounters Among Adults With Opioid Use Disorder.
    Hawk K; McCormack R; Edelman EJ; Coupet E; Toledo N; Gauthier P; Rotrosen J; Chawarski M; Martel S; Owens P; Pantalon MV; O'Connor P; Whiteside LK; Cowan E; Richardson LD; Lyons MS; Rothman R; Marsch L; Fiellin DA; D'Onofrio G
    JAMA Netw Open; 2022 Jan; 5(1):e2144955. PubMed ID: 35076700
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Organizational factors associated with practitioners' support for treatment of opioid use disorder in the emergency department.
    Guerrero E; Ober AJ; Howard DL; Khachikian T; Kong Y; van Deen WK; Valdez A; Trotzky-Sirr R; Menchine M
    Addict Behav; 2020 Mar; 102():106197. PubMed ID: 31862684
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Variation in emergency department visit rates for opioid use disorder: Implications for quality improvement initiatives.
    Khatri UG; Samuels EA; Xiong R; Marshall BDL; Perrone J; Delgado MK
    Am J Emerg Med; 2022 Jan; 51():331-337. PubMed ID: 34800906
    [TBL] [Abstract][Full Text] [Related]  

  • 37. PRimary Care Opioid Use Disorders treatment (PROUD) trial protocol: a pragmatic, cluster-randomized implementation trial in primary care for opioid use disorder treatment.
    Campbell CI; Saxon AJ; Boudreau DM; Wartko PD; Bobb JF; Lee AK; Matthews AG; McCormack J; Liu DS; Addis M; Altschuler A; Samet JH; LaBelle CT; Arnsten J; Caldeiro RM; Borst DT; Stotts AL; Braciszewski JM; Szapocznik J; Bart G; Schwartz RP; McNeely J; Liebschutz JM; Tsui JI; Merrill JO; Glass JE; Lapham GT; Murphy SM; Weinstein ZM; Yarborough BJH; Bradley KA
    Addict Sci Clin Pract; 2021 Jan; 16(1):9. PubMed ID: 33517894
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Barriers and facilitators to implementing treatment for opioid use disorder in community hospitals.
    Shearer R; Hagedorn H; Englander H; Siegler T; Kibben R; Fawole A; Patten A; Fitzpatrick A; Laes J; Fernando J; Appleton N; Oot E; Titus H; Krawczyk N; Weinstein Z; McNeely J; Baukol P; Ghitza U; Gustafson D; Bart G; Bazzi A
    J Subst Use Addict Treat; 2024 Dec; 167():209520. PubMed ID: 39265915
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Implementation strategies to address the determinants of adoption, implementation, and maintenance of a clinical decision support tool for emergency department buprenorphine initiation: a qualitative study.
    Simpson MJ; Ritger C; Hoppe JA; Holland WC; Morris MA; Nath B; Melnick ER; Tietbohl C
    Implement Sci Commun; 2023 Apr; 4(1):41. PubMed ID: 37081581
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A scalable, automated warm handoff from the emergency department to community sites offering continued medication for opioid use disorder: Lessons learned from the EMBED trial stakeholders.
    Ahmed OM; Mao JA; Holt SR; Hawk K; D'Onofrio G; Martel S; Melnick ER
    J Subst Abuse Treat; 2019 Jul; 102():47-52. PubMed ID: 31202288
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 32.